Erica Ollmann Saphire
Erica Ollmann Saphire is an American structural biologist and immunologist and a professor at the La Jolla Institute for Immunology. She investigates the structural biology of viruses that cause hemorrhagic fever such as Ebola, Sudan, Marburg, Bundibugyo, and Lassa.Saphire has served as president and CEO of La Jolla Institute for Immunology since 2021. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Erica Ollmann Saphire', query time: 0.01s
Refine Results
-
1
Mapping the antibody response to Lassa virus vaccination of non-human primatesResearch in context by Adrian S. Enriquez, Ruben Diaz Avalos, Diptiben Parekh, Christopher L. Cooper, Gavin Morrow, Thomas W. Geisbert, Christopher L. Parks, Kathryn M. Hastie, Erica Ollmann Saphire
Published 2025-04-01Get full text
Article -
2
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses by Michelle Meyer, Bronwyn M. Gunn, Colette Pietzsch, Chandru Subramani, Kritika Kedarinath, Paula P. Villarreal, Matthew A. Hyde, Erica Ollmann Saphire, James E. Crowe, Galit Alter, Sunny Himansu, Andrea Carfi, Alexander Bukreyev
Published 2025-07-01Get full text
Article -
3
Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. by Shridhar Bale, Jean-Philippe Julien, Zachary A Bornholdt, Christopher R Kimberlin, Peter Halfmann, Michelle A Zandonatti, John Kunert, Gerard J A Kroon, Yoshihiro Kawaoka, Ian J MacRae, Ian A Wilson, Erica Ollmann Saphire
Published 2012-09-01Get full text
Article -
4
Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment by Sara Landeras-Bueno, Chitra Hariharan, Ruben Diaz Avalos, Andrew S. Norris, Dalton T. Snyder, Kathryn M. Hastie, Stephanie Harkins, Michelle Zandonatti, Roshan R. Rajamanickam, Eduardo Olmedillas, Robyn Miller, Sujan Shresta, Vicki H. Wysocki, Erica Ollmann Saphire
Published 2025-07-01Get full text
Article -
5
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane by Kathryn M. Hastie, Zhe Li Salie, Zunlong Ke, Peter J. Halfmann, Lisa Evans DeWald, Sara McArdle, Ariadna Grinyó, Edgar Davidson, Sharon L. Schendel, Chitra Hariharan, Michael J. Norris, Xiaoying Yu, Chakravarthy Chennareddy, Xiaoli Xiong, Megan Heinrich, Michael R. Holbrook, Benjamin Doranz, Ian Crozier, Yoshihiro Kawaoka, Luis M. Branco, Jens H. Kuhn, John A. G. Briggs, Gabriella Worwa, Carl W. Davis, Rafi Ahmed, Erica Ollmann Saphire
Published 2025-02-01Get full text
Article -
6
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context by Christopher L. Cooper, Gavin Morrow, Maoli Yuan, Thomas S. Postler, Maxwell L. Neal, Robert W. Cross, Courtney Woolsey, Krystle N. Agans, Viktoriya Borisevich, Ryan P. McNamara, Caroline Atyeo, Vicky Roy, Daritza Germosen, Fuxiang Hou, Shui L. Li, Lucia Reiserova, Yesle Choi, Aaron Wilson, Denise Wagner, Olivia Wallace-Selman, Alexei Carpov, Fuqiang Geng, Deborah J. Frederick, Joanne DeStefano, Anne M. Ercolini, Adrian S. Enriquez, Kathryn M. Hastie, Suzane Ramos da Silva, Eddy Sayeed, John W. Coleman, Andrew Kilianski, Galit Alter, Erica Ollmann Saphire, John D. Aitchison, Thomas W. Geisbert, Swati B. Gupta, Mark B. Feinberg, Christopher L. Parks
Published 2025-04-01Get full text
Article